Corrigendum to ‘A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption’ [Clin. Immunol. 142 (2012) 252–268].

Authors :: Allard, Sabine D.
De Keersmaecker, Brenda
de Goede, Anna L.
Verschuren, Esther J.
Koetsveld, Jeanette
Reedijk, Mariska L.
Wylock, Carolien
De Bel, Annelies V.
Vandeloo, Judith
Pistoor, Frank
Heirman, Carlo
Beyer, Walter E.P.
Eilers, Paul H.C.
Corthals, Jurgen
Padmos, Iman
Thielemans, Kris
Osterhaus, Albert D.M.E.
Lacor, Patrick
van der Ende, Marchina E.
Aerts, Joeri L.
Source :: Clinical Immunology. Jan2014, Vol. 150 Issue 1, p88-89. 2p.
Publication Year :: 2014

Full Text Access

Tools